Skip to content

Is Nayzilam the Same as Versed? A Look at Midazolam's Different Forms

4 min read

Nayzilam and Versed are both brand names for the powerful sedative and anxiolytic drug midazolam, a Schedule IV controlled substance due to its potential for abuse and dependence. However, the crucial distinction in how they are formulated, administered, and used means that Nayzilam is not the same as Versed.

Quick Summary

Nayzilam is a midazolam nasal spray for at-home seizure clusters in epileptics, while Versed was a brand name for midazolam injections or syrup for clinical sedation.

Key Points

  • Same Active Ingredient: The core substance in both Nayzilam and Versed is midazolam, a fast-acting benzodiazepine.

  • Different Formulations: Nayzilam is a ready-to-use nasal spray for outpatient use, while Versed was associated with injectable (IV, IM) and oral syrup forms for in-hospital procedures.

  • Distinct Indications: Nayzilam is specifically approved for acute treatment of seizure clusters at home, whereas midazolam injections are used for procedural sedation and status epilepticus in monitored clinical settings.

  • Administered Differently: Nayzilam can be administered by a trained caregiver outside of a hospital, while generic midazolam injections must be given by a healthcare professional in a controlled environment.

  • Shared Safety Concerns: Both forms carry risks of CNS depression, respiratory issues, abuse, and dependence. They are both Schedule IV controlled substances.

In This Article

The active ingredient in both Nayzilam and Versed is midazolam, a benzodiazepine that acts as a central nervous system depressant. The confusion about whether they are the same is understandable, given they share the same core drug. However, the differences lie in their specific formulation, intended use, and method of administration. Nayzilam is a newer, ready-to-use nasal spray for managing seizure clusters at home, whereas Versed was a brand name primarily associated with injectable and oral formulations used for supervised sedation in a clinical environment.

The Shared Root: Midazolam

Midazolam is a benzodiazepine that works by enhancing the effects of gamma-aminobutyric acid (GABA), a neurotransmitter that inhibits nerve transmission in the brain. This potentiation of GABA leads to a calming effect on the nervous system, which provides sedative, anxiolytic, and anticonvulsant properties. The fast-acting nature of midazolam makes it valuable for rapidly stopping seizures or inducing relaxation. As a Schedule IV controlled substance, it carries a risk of abuse, misuse, and addiction, and its use is regulated.

Nayzilam: The Outpatient Seizure Rescue Spray

Nayzilam is a prescription medicine containing midazolam that is specifically approved for the acute treatment of intermittent episodes of frequent seizure activity (seizure clusters) in patients with epilepsy who are 12 years of age or older. Key features of Nayzilam include:

  • Formulation: A single-use, prefilled nasal spray device.
  • Administration: Designed for easy administration by a caregiver or patient in an outpatient setting, such as at home or school.
  • Use: Intended for intermittent, short-term use, not as a daily epilepsy medication.
  • Administration Guidelines: Specific instructions for administration should be followed as prescribed by a healthcare provider.

Versed: The Clinical Sedative (and a historical note)

The brand name Versed, referring to midazolam, has been discontinued, but generic midazolam remains widely available in various formulations. Generic midazolam is typically used in the following settings:

  • In-hospital sedation: Administered via intravenous (IV) or intramuscular (IM) injection to induce sedation before surgical or diagnostic procedures.
  • Conscious sedation: Used during minor medical procedures to help patients relax and to cause anterograde amnesia, so they don't remember the procedure.
  • Status epilepticus: Injectable midazolam is used in emergency settings to treat long-lasting seizures.
  • Pediatric sedation: An oral syrup formulation is often used for pediatric patients before procedures.

A Look at Administration Methods

The route of administration is one of the most significant differences between Nayzilam and the generic versions of injectable midazolam (formerly Versed). The nasal spray route for Nayzilam offers several advantages for emergency seizure management:

  • It is non-invasive and can be given even if the person is unconscious, without requiring IV access.
  • It is designed for rapid delivery outside of a hospital setting.

In contrast, generic midazolam injections are administered by a healthcare provider in a controlled, monitored environment, as they can cause serious respiratory depression and require close supervision.

Nayzilam vs. Versed: A Comparative Analysis

Feature Nayzilam Versed (Generic Midazolam)
Active Ingredient Midazolam Midazolam (e.g., midazolam hydrochloride)
Primary Formulations Single-dose nasal spray Injection (IV, IM) and oral syrup
Primary Use Acute treatment of seizure clusters in patients 12+ Procedural sedation, anxiety relief, treatment of status epilepticus
Administration Setting Outpatient (e.g., home, school) by a caregiver or patient Supervised clinical setting (hospital, clinic) by a healthcare provider
Administration Method Nasal spray into the nostril Injection into a vein or muscle, or oral syrup
Duration of Effect Rapid onset (minutes), can prevent further seizures for hours Rapid onset (minutes) with effects lasting for a few hours, depending on dose
Patient Age 12 years and older Various, including pediatric oral syrup

The Implications of Formulations: Why the Difference Matters

The contrasting formulations and uses of these midazolam products are critical to patient safety and clinical practice. The development of Nayzilam as a nasal spray represents a significant advancement in emergency seizure care, empowering caregivers to intervene quickly and non-invasively to stop a seizure cluster and potentially prevent a hospital visit. Meanwhile, the generic midazolam injectable and oral forms remain indispensable in medical settings where controlled, rapid sedation is required, or for treating more severe, long-lasting seizures (status epilepticus).

Important Safety Considerations

As with all benzodiazepines, both products require careful use. Key risks include central nervous system depression, which can cause severe drowsiness and potentially life-threatening breathing problems, especially when combined with opioids or alcohol. The potential for abuse and dependence is a significant concern, and patients should never exceed prescribed dosages or use the medication more frequently than directed. Abrupt discontinuation of benzodiazepines, especially if used frequently, can lead to severe withdrawal reactions. Patients with certain conditions, such as acute narrow-angle glaucoma, should not use midazolam. You can find more information from authoritative sources, such as the Epilepsy Foundation.

Conclusion: Same Core Drug, Different Clinical Tools

In summary, while Nayzilam and Versed both contain the same active ingredient, midazolam, they are not the same product. Their fundamental differences in formulation, intended use, and administration setting make them distinct clinical tools. Nayzilam is a purpose-built nasal spray for at-home seizure rescue, while generic midazolam (formerly branded as Versed) is used in hospitals for sedation during medical procedures or for severe, long-lasting seizures. Understanding these key differences is essential for both healthcare providers and patients to ensure appropriate and safe use.

Frequently Asked Questions

The active ingredient in both Nayzilam and Versed (or its generic form) is midazolam, a benzodiazepine that acts as a central nervous system depressant.

Nayzilam is formulated as a nasal spray to allow for rapid, non-invasive administration at home or school by a caregiver during an episode of seizure clusters.

The brand name Versed has been discontinued, but generic versions of midazolam injections and oral syrup are still widely used in supervised clinical settings.

No, Nayzilam is specifically indicated for the acute treatment of seizure clusters and is not approved for procedural sedation.

Yes, both Nayzilam and generic midazolam carry risks of abuse, misuse, addiction, and dependence. Abruptly stopping them can cause withdrawal symptoms.

Nayzilam is not for daily use. The recommended frequency is no more than one episode every three days and no more than five episodes per month.

Nayzilam is used for seizure clusters. A healthcare provider will create a personalized Seizure Action Plan to determine when and how to use it appropriately, based on the patient's specific seizure patterns.

Common side effects include sleepiness, headache, nasal discomfort, throat irritation, and a runny nose.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.